Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial

Once-Weekly Semaglutide in Adults with Overweight or Obesity

John Wilding, Rachel L. Batterham, Salvatore Calanna et al. · New England Journal of Medicine · 2021 · 4.5K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

European Guidelines for Obesity Management in Adults

Volkan Yumuk, Constantine Tsigos, Martin Fried et al. · Obesity Facts · 2015 · 3.4K citations · Full text

Agriculture, Nutrition, Nutritional Sciences +8

Statistical Analysis with Missing Data

Subir Ghosh, Roderick J. A. Little, Donald B. Rubin · Technometrics · 1988 · 3.1K citations

Natural Sciences, Biostatistics, Mathematics +12

American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity

W. Timothy Garvey, Jeffrey I. Mechanick, Elise M. Brett et al. · Endocrine Practice · 2016 · 1.8K citations

Medicine, Endocrinology, Internal Medicine +15

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity

Domenica Rubino, Niclas Abrahamsson, Melanie J. Davies et al. · JAMA · 2021 · 1.2K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17